FDA applicant
Taiwan Main Orthopaedic Biotechnology Co., Ltd.
FDA records 3 decisions for Taiwan Main Orthopaedic Biotechnology Co., Ltd. (Taichung City, TW) from 2022 to 2026: 3 510(k) clearances. Most are in product codes SBF (Orthopedic Augmented Reality) and LLZ (System, Image Processing, Radiological). Since 2016 its 510(k)s took a median of 260 days from receipt to decision, against 110 for FDA’s reviews in the same codes and years. Its devices cite 3 predicates, 0 of them its own earlier devices. No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Taiwan Main Orthopaedic Biotechnology Co., Ltd.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2024
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2022.
Planning a device like Taiwan Main Orthopaedic Biotechnology…’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report